{"id":"NCT01370005","sponsor":"Boehringer Ingelheim","briefTitle":"12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus","officialTitle":"A Phase III Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of BI 10773 (10 mg, 25 mg) Administered Orally, Once Daily Over 12 Weeks in Hypertensive Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-06","primaryCompletion":"2012-07","completion":"2012-07","firstPosted":"2011-06-09","resultsPosted":"2014-06-17","lastUpdate":"2016-02-22"},"enrollment":825,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2","Hypertension"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"BI 10773","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"BI 10773","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"BI 10773 low dose","type":"EXPERIMENTAL"},{"label":"BI 10773 high dose","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This trial will evaluate safety and efficacy of BI 10773 in hypertensive patients with type 2 diabetes. Since hyperglycaemia and hypertension are key risk factors for both micro- and macrovascular complications, assessment of both glucose and blood pressure lowering effects of BI 10773 in hypertensive patients with type 2 diabetes could provide clinically highly relevant, new information for the use of BI 10773","primaryOutcome":{"measure":"HbA1c Change From Baseline","timeFrame":"Baseline and 12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":0.03,"sd":0.6},{"arm":"Empa 10mg","deltaMin":-0.59,"sd":0.63},{"arm":"Empa 25mg","deltaMin":-0.63,"sd":0.62}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":120,"countries":["United States","Canada","Czechia","Denmark","Estonia","Finland","France","Germany","Lebanon","Netherlands","Norway","Sweden"]},"refs":{"pmids":["38770818","35472672","27977392","25271206"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":272},"commonTop":["Nasopharyngitis","Hypoglycaemia","Pollakiuria","Thirst"]}}